Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 39, Issue 2, Pages BSR20182306
Publisher
Portland Press Ltd.
Online
2019-02-14
DOI
10.1042/bsr20182306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression
- (2018) Takashi Seino et al. Cell Stem Cell
- Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis
- (2018) Zhou Zhou et al. International Journal of Biological Sciences
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells
- (2017) Yu Zhang et al. Nutrients
- Prognostic and predictive markers in pancreatic adenocarcinoma
- (2016) Nha Le et al. DIGESTIVE AND LIVER DISEASE
- Genetics and biology of pancreatic ductal adenocarcinoma
- (2016) Haoqiang Ying et al. GENES & DEVELOPMENT
- Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway
- (2016) Fan Yang et al. Oncotarget
- Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
- (2016) A. Marcell Szász et al. Oncotarget
- CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
- (2016) Sara Costa-Cabral et al. PLoS One
- Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells
- (2015) Wan Feng et al. BIOMEDICINE & PHARMACOTHERAPY
- Genetics and Biology of Pancreatic Ductal Adenocarcinoma
- (2015) Richard F. Dunne et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer
- (2015) Qinghua Xi et al. TUMOR BIOLOGY
- A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage
- (2015) Mariana F. Gayyed et al. TUMOR BIOLOGY
- Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses
- (2015) JIN LONG et al. Oncology Letters
- Big Data for Health
- (2015) Javier Andreu-Perez et al. IEEE Journal of Biomedical and Health Informatics
- High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
- (2015) Wen-Wei Sung et al. BMC CANCER
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cdc20 and securin overexpression predict short-term breast cancer survival
- (2014) H Karra et al. BRITISH JOURNAL OF CANCER
- Big Data Bioinformatics
- (2014) Casey S. Greene et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance
- (2014) Tian Gao et al. PLoS One
- Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
- (2014) Andrew E Becker WORLD JOURNAL OF GASTROENTEROLOGY
- Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
- (2013) J M Willder et al. BRITISH JOURNAL OF CANCER
- Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
- (2013) Zhiwei Wang et al. CURRENT PHARMACEUTICAL DESIGN
- High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma
- (2013) Inês M. B. Moura et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
- (2013) Wen-jing Wu et al. Journal of Translational Medicine
- Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women
- (2013) Yan Li et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer
- (2013) Jung-Woo Choi et al. VIRCHOWS ARCHIV
- Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) T. Seufferlein et al. ANNALS OF ONCOLOGY
- Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
- (2012) David Z Chang et al. Journal of Hematology & Oncology
- Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients
- (2012) Tatsuya Kato et al. JOURNAL OF SURGICAL ONCOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line
- (2011) Igor Tsaur et al. CANCER LETTERS
- Spindle proteins in resected pancreatic head adenocarcinomas: BubR1 is an independent prognostic factor in pancreatobiliary-type tumours
- (2010) Ivar P Gladhaug et al. HISTOPATHOLOGY
- Towards a knowledge-based Human Protein Atlas
- (2010) Mathias Uhlen et al. NATURE BIOTECHNOLOGY
- High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer
- (2009) Koji Ando et al. CANCER SCIENCE
- The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma
- (2009) A-W Liu et al. JOURNAL OF CLINICAL PATHOLOGY
- Mitotic Checkpoint Genes, hsMAD2 and BubR1, in Oesophageal Squamous Cancer Cells and their Association with 5-fluorouracil and Cisplatin-based Radiochemotherapy
- (2008) K. Tanaka et al. CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started